1.《中华人民共和国药品管理法》
Drug Control Law of the People's Republic of China

2.药品生产企业管理
control over drug manufacturers

3.药品经营企业管理
control over drug distributors

4.医疗机构的药剂管理
control over medicines in medical institutions

5.药品管理
control over drugs

6.药品包装的管理
control over drug packaging

7.药品价格和广告的管理
control over drug price and advertisement

8.药品监督
inspection of drugs

9.法律责任
legal liabilities

10.药品标识
labels or marks of the drugs

11.假药
counterfeit drugs

12.劣药
inferior drugs

13.药品检验机构
drug quality control laboratory

14.药品的生产企业
drug manufacturers

15.经营企业
drug distributors

16.医疗机构
medical institutions

17.药品监督管理部门
drug regulatory agency

18.药品批准证明文件
drug approval documents

19.行政处分
administrative sanctions

20.刑事责任
criminal liabilities

21.药品生产质量管理规范
Good Manufacturing Practice for Pharmaceutical Products (GMP)

22.药品经营质量管理规范
Good Supply Practice for Pharmaceutical Products (GSP)

23.药品生产许可证
Drug Manufacturing Certificate

24.药品经营许可证
Drug Supply Certificate

25.医疗机构制剂许可证
Pharmaceutical Preparation Certificate for Medical Institution

26.进口药品注册证书
Import Drug License

27.临床试验
clinical trial

28.新药证书
New Drug Certificate

29.药品批准文号
Drug Approval Number

30.在中华人民共和国境内从事药品的研制、生产、经营、使用和监督管理的单位或者个人，必须遵守《中华人民共和国药品管理法》
All institutions or individuals engaged in research, production, distribution, use, and administration and supervision of drugs in the People's Republic of China shall abide by drug control law of the people's republic of China.

31.国务院药品监督管理部门主管全国药品监督管理工作。
The drug regulatory agency of the State Council shall be responsible for drug administration and supervision nationwide.

32.省、自治区、直辖市人民政府药品监督管理部门负责本行政区域内的药品监督管理工作。
The drug regulatory agencies of the governments of provinces, autonomous regions, and municipalities directly under the Central Government shall be responsible for drug regulation in their administrative areas.

33.药品监督管理部门设置或者确定的药品检验机构，承担依法实施药品审批和药品质量监督检查所需的药品检验工作。
The drug quality control laboratories established or designated by drug regulatory agencies shall undertake the responsibility for drug testing required for conducting drug review and approval and controlling drug quality pursuant to the law.

34.开办药品生产企业，须经企业所在地省、自治区、直辖市人民政府药品监督管理部门批准并发给《药品生产许可证》，凭《药品生产许可证》到工商行政管理部门办理登记注册。
Any newly established pharmaceutical manufacturer shall be subject to approval by the local drug regulatory agency of the government of the province, autonomous region or municipality directly under the Central Government and be granted the Drug Manufacturing Certificate, and, with the certificate, the manufacturer shall be registered with the administrative agency for industry and commerce.

35.《药品生产许可证》应当标明有效期和生产范围，到期重新审查发证。
The term of validation and the scope of manufacturing shall be noted in the Drug Manufacturing Certificate. For renewal of the certificate on expiration, reviewing and approval again is required.

36.药品监督管理部门批准开办药品生产企业，应当符合国家制定的药品行业发展规划和产业政策，防止重复建设。
When giving approval to the newly-established manufacturer, the drug regulatory agency shall see to it that the development programs and policies set by the State for the pharmaceutical industry shall be complied with so as to prevent duplicate construction.

37.开办药品生产企业，必须具备以下条件：（一）具有依法经过资格认定的药学技术人员、工程技术人员及相应的技术工人；（二）具有与其药品生产相适应的厂房、设施和卫生环境；（三）具有能对所生产药品进行质量管理和质量检验的机构、人员以及必要的仪器设备；（四）具有保证药品质量的规章制度。
Any drug manufacturer to be established shall meet the following requirements: (1) stuffed with legally qualified pharmaceutical and engineering professionals and the necessary technical workers;(2) provided with the premises, facilities, and clear environment required for drug manufacturing; (3) having quality management and control units and personnel capable of quality management of and testing for drugs to be produced and the necessary instruments and equipment; and (4) establishing rules and regulations to govern the quality of drugs.

38.药品生产企业必须按照国务院药品监督管理部门依据本法制定的《药品生产质量管理规范》组织生产。药品监督管理部门按照规定对药品生产企业是否符合《药品生产质量管理规范》的要求进行认证；对认证合格的，发给认证证书。
Drug manufacturers shall conduct production according to the Good Manufacturing Practice Products (GMP) formulated by the drug regulatory agency of the State Council based on this Law. The drug regulatory agency shall inspect a drug manufacturer as to its compliance with the GMP requirements and issue a certificate to the manufacturer passing the inspection.

39.除中药饮片的炮制外，药品必须按照国家药品标准和国务院药品监督管理部门批准的生产工艺进行生产，生产记录必须完整准确。
With the exception of the processing of prepared slices of  Chinese crude drugs, a drug shall be produced in  conformity  with  the  National Drug Standard and  with the production processes approved by  the  drug regulatory  agency of the State Council, and the production records shall be complete and accurate.

40.药品生产企业改变影响药品质量的生产工艺的，必须报原批准部门审核批准。
When drug manufacturers make any change in the production process that may affect the drug quality, they shall submit the change to the original authority for reviewing and approval.

41.生产药品所需的原料、辅料，必须符合药用要求。   
Active pharmaceutical ingredients (API) and recipients for the manufacture of pharmaceutical products shall meet the requirements for medicinal use.

42.药品生产企业必须对其生产的药品进行质量检验。
Drug manufacturers shall perform quality test of their products.

43.不符合国家药品标准或者不按照省、自治区、直辖市人民政府药品监督管理部门制定的中药饮片炮制规范炮制的，不得出厂。
No products that do not meet the  National Drug Standards or that are not produced according to the processing procedures for the prepared slices of Chinese crude drugs formulated by the drug regulatory agency of the government of a province, autonomous region, or municipality directly under the Central Government may be released.

44.经国务院药品监督管理部门或者国务院药品监督管理部门授权的省、自治区、直辖市人民政府药品监督管理部门批准，药品生产企业可以接受委托生产药品。
A drug manufacturer may not accept any contract production of drugs unless it is approved by the drug regulatory agency of the State Council, or by the drug regulatory agency of the government of a province, autonomous region, or municipality directly under the Central Government authorized by the drug regulatory agency of the State Council.

45.开办药品批发企业，须经企业所在地省、自治区、直辖市人民政府药品监督管理部门批准并发给《药品经营许可证》.
Any newly established drug wholesaler shall be subject to approval of the local drug agency of the government of the province, autonomous region or municipality directly under the Central Government and be granted the Drug Supply Certificate.

46.开办药品零售企业，须经企业所在地县级以上地方药品监督管理部门批准并发给《药品经营许可证》。
Any newly established drug retailer shall be subject to approval and be granted the above certificate by the local drug regulatory agency at or above the county level.

47. 药品批发、零售企业凭《药品经营许可证》到工商行政管理部门办理登记注册。
With the Drug Supply Certificate , the wholesaler and the retailer shall be registered with the administrative agency for industry and commerce.

47.无《药品经营许可证》的，不得经营药品。
No one is permitted to distribute drugs without the certificate.

48.《药品经营许可证》应当标明有效期和经营范围，到期重新审查发证。
The valid period and the scope of business shall be indicated in the Drug Supply Certificate. For renewal of the certificate upon expiration, reviewing and approval again is required.

49.开办药品经营企业必须具备以下条件： （一）具有依法经过资格认定的药学技术人员；（二）具有与所经营药品相适应的营业场所、设备、仓储设施、卫生环境；（三）具有与所经营药品相适应的质量管理机构或者人员；（四）具有保证所经营药品质量的规章制度。
A drug distributor to be established shall meet the following requirements:(1) staffed with legally qualified pharmaceutical professionals;(2) provided with the business operation premises, equipment, warehouses, and clear environment required for drug distribution;(3) having the quality control units or personnel adaptable the drugs to be distributed; and(4) establishing rules and regulations to govern the quality of the drugs to be distributed.

50.药品经营企业必须按照国务院药品监督管理部门依据本法制定的《药品经营质量管理规范》经营药品。
Drug distributors shall conduct business according to the Good Supply Practice for Pharmaceutical Products (GSP) set by the drug regulatory agency of the State Council based on this Law.

51.药品监督管理部门按照规定对药品经营企业是否符合《药品经营质量管理规范》的要求进行认证；对认证合格的，发给认证证书。
The drug regulatory agency inspect a drug distributor as to its compliance with the GSP requirements, and issue a certificate to the distributor passing the inspection.

52.药品经营企业购进药品，必须建立并执行进货检查验收制度，验明药品合格证明和其他标识；不符合规定要求的，不得购进。
After receiving the drug purchased, drug distributors shall pass the established examination and acceptance system, and check the certificate of drug quality, labels and others marks; no drugs that fail to meet the requirements are permitted to be purchased.

53.药品经营企业购销药品，必须有真实完整的购销记录。
Drug distributors shall keep a real and perfect records of purchasing and selling drugs.

54.购销记录必须注明药品的通用名称、剂型、规格、批号、有效期、生产厂商、购（销）货单位、购（销）货数量、购销价格、购（销）货日期及国务院药品监督管理部门规定的其他内容。
In the record shall be indicated the adopted name of drugs, dosage form, strength or size, batch number, date of expiry, manufacturer, purchaser (or seller), amount of the drug purchased (or sold), purchase or selling price, date of purchase (or sale) , and other items specified by the drug regulatory agency of the State Council.

55.药品经营企业销售中药材，必须标明产地。
Drug distributors shall indicate the habitat of Chinese crude drugs to be sold.

56.药品经营企业必须制定和执行药品保管制度，采取必要的冷藏、防冻、防潮、防虫、防鼠等措施，保证药品质量。
A drug distributor shall pass the established system for drug storage, and take necessary measures to ensure drug quality, such as cold storing, protecting from being frozen and moisture and guarding against insects and rodents.

57.药品入库和出库必须执行检查制度。
An examination system shall be followed for storing drugs in warehouse and releasing them from warehouse.

58.城乡集市贸易市场可以出售中药材，国务院另有规定的除外。
Chinese crude drugs may be sold at fairs in urban and rural areas, except those otherwise specified by the State Council.

59.城乡集市贸易市场不得出售中药材以外的药品，但持有《药品经营许可证》的药品零售企业在规定的范围内可以在城乡集市贸易市场设点出售中药材以外的药品。
No drugs other than the Chinese crude drugs may be sold at fairs in urban and rural areas, but drug retailers holding the Drug Supply Certificate may, within the specified business scope, sell such drugs at the stores they set up at the fairs.

60.医疗机构配制制剂，须经所在地省、自治区、直辖市人民政府卫生行政部门审核同意，由省、自治区、直辖市人民政府药品监督管理部门批准，发给《医疗机构制剂许可证》。
Dispensing pharmaceutical preparations by a medical institution shall be subject to reviewing and permission by the health administration agency of the government of the province, autonomous region or municipality directly under the Central Government, and upon approval by the drug regulatory agency of the government. A Pharmaceutical Preparation Certificate for Medical Institution shall be issued by the above drug regulatory agency.

61.无《医疗机构制剂许可证》的医疗机构，不得配制制剂。
No medical institution is permitted to dispense pharmaceutical preparations without the Pharmaceutical Preparation Certificate for Medical Institution.

62.《医疗机构制剂许可证》应当标明有效期，到期重新审查发证。
The term of validation shall be noted in the Pharmaceutical Preparation Certificate for Medical Institution. For renewal of the certificate upon expiration, reviewing and approval again is required.

63.医疗机构配制的制剂，应当是本单位临床需要而市场上没有供应的品种，并须经所在地省、自治区、直辖市人民政府药品监督管理部门批准后方可配制。
The pharmaceutical preparations to be dispensed by the medical institution shall be those satisfying the clinic need of the institution but not available on the market. It shall be subject to approval in advance by the local drug regulatory agency of the government of the province, autonomous region or municipality directly under the Central Government.

64.医疗机构配制的制剂，不得在市场销售。
No pharmaceutical preparations dispensed by medical institutions are permitted to be marketed.

65.研制新药，必须按照国务院药品监督管理部门的规定如实报送研制方法、质量指标、药理及毒理试验结果等有关资料和样品，经国务院药品监督管理部门批准后，方可进行临床试验。
A full description of a new drug research and development including the manufacturing process, quality specifications, results of pharmacological and toxicological study, and the related data as well as the samples shall, in accordance with the regulations of the drug regulatory agency of the State Council, be truthfully submitted to the above agency for reviewing and approval.

66.完成临床试验并通过审批的新药，由国务院药品监督管理部门批准，发给新药证书。
When a new drug has gone through clinical trials and passed the reviewing, a New Drug Certificate shall be issued upon approval by the drug regulatory agency of the State Council.

67.药物的非临床安全性评价研究机构和临床试验机构必须分别执行药物非临床研究质量管理规范、药物临床试验质量管理规范。
The institutions for non-clinical safety evaluation and study and for clinical study institutions shall respectively follow the Good Laboratory Practice for Non-Clinical Laboratory Studies (GLP) and Good Clinical Practice (GCP).

70.药品生产企业在取得药品批准文号后，方可生产该药品。
A drug manufacturer is permitted to produce the drug only after an approval number has been granted to it.

71. 药品必须符合国家药品标准。
Drugs shall comply with the National Drug Standards.

72.国务院药品监督管理部门颁布的《中华人民共和国药典》和药品标准为国家药品标准。
The Pharmacopoeia of the People's Republic of China and the Drug Standards issued by the drug regulatory agency of the State Council shall serve as the National Drug Standards.

73.国务院药品监督管理部门组织药典委员会，负责国家药品标准的制定和修订。
The drug regulatory agency of the State Council shall organize a pharmacopoeia commission, which shall be responsible for formulating and revising the National Drug Standards.

74.国务院药品监督管理部门的药品检验机构负责标定国家药品标准品、对照品。
The drug control institution affiliated to the drug regulatory agency of the State Council is responsible for standardizing the National Drug Standard Substance and Reference Substance.

75.药品生产企业、药品经营企业、医疗机构必须从具有药品生产、经营资格的企业购进药品；但是，购进没有实施批准文号管理的中药材除外。
Drug manufacturers, drug distributors and medical institutions shall purchase drugs from pharmaceutical enterprises, which are qualified for production and distribution, with the exception of the Chinese crude drugs in which no control by approval number is exercised.

76.国家对麻醉药品、精神药品、医疗用毒性药品、放射性药品，实行特殊管理。
The State exercises special control over narcotic drugs, psychotropic substances, toxic drugs for medical use and radioactive pharmaceuticals.

77.国家实行中药品种保护制度。
The State adopts a protection system for certain traditional Chinese medicines.

78.国家对药品实行处方药与非处方药分类管理制度。
The State adopts a system of classified management for prescription and non-prescription drugs.

79.药品进口，须经国务院药品监督管理部门组织审查，经审查确认符合质量标准、安全有效的，方可批准进口，并发给进口药品注册证书。
Reviewing the drugs to be imported shall come of the jurisdiction of the drug regulatory agency of the State Council. A drug is permitted to be imported only upon approval granted after confirming that it conforms to the quality, safely and efficiency through examination, and a drug importation license shall be issued.

80.国家实行药品储备制度。
The State adopts a policy for drug storage for future use.

81.国内发生重大灾情、疫情及其他突发事件时，国务院规定的部门可以紧急调用企业药品。
When major disasters, epidemic situations or other emergencies occur in the country, the department designated by the State Council may allocate drugs from the enterprises to meet the urgent need.

82. 禁止生产（包括配制）、销售假药。
Production (including dispensing) and distribution of counterfeit drugs are prohibited.

83.有下列情形之一的，为假药：
A drug falling into the following categories is deemed as a counterfeit drug:
（一）药品所含成份与国家药品标准规定的成份不符的；
The ingredients in the drug are different from those specified by the National Drug Standards;
（二）以非药品冒充药品或者以他种药品冒充此种药品的。
It is not the same drug which is claimed by its name or in reality it is not a drug at all.

 

84.有下列情形之一的药品，按假药论处：
A drug falling into the following categories shall be deemed as a counterfeit drug:
（一）国务院药品监督管理部门规定禁止使用的；
It’s use is prohibited by the provisions of the drug regulatory agency of the State Council;
（二）依照本法必须批准而未经批准生产、进口，或者依照本法必须检验而未经检验即销售的；
It is produced or imported without approval, or marketed without being tested, as required by the Law;
（三）变质的；
It is deteriorated;
（四）被污染的；
It is contaminated;  
（五）使用依照本法必须取得批准文号而未取得批准文号的原料药生产的；
It is produced by using active pharmaceutical ingredients without approval number as required by this Law;
（六）所标明的适应症或者功能主治超出规定范围的。
The indications or functions indicated are beyond the specified scope.

85. 禁止生产、销售劣药。
Production and distribution of drugs of inferior quality are prohibited.

86.药品成份的含量不符合国家药品标准的，为劣药。
A drug with content not up to the National Drug Standards is a drug of inferior quality.

87.有下列情形之一的药品，按劣药论处：
A drug falling into the following categories shall be deemed as a drug of inferior quality:
（一）未标明有效期或者更改有效期的；
The date of expiry is not indicated or is altered;
（二）不注明或者更改生产批号的；
The batch number is not indicated or is altered;
（三）超过有效期的；
It is beyond the date of expiry;
（四）直接接触药品的包装材料和容器未经批准的；
No approval certificate is obtained for the immediate packaging material or container;
（五）擅自添加着色剂、防腐剂、香料、矫味剂及辅料的；
Colorants, preservatives, spices, flavorings, or other recipients have been added without authorization; or
（六）其他不符合药品标准规定的。
Other cases where the drug standards are not complied with.

88.列入国家药品标准的药品名称为药品通用名称。已经作为药品通用名称的，该名称不得作为药品商标使用。
A drug name listed in the National Drug Standards is an adopted name in China. Such an adopted name is not permitted to be used as a trademark.

89.药品生产企业、药品经营企业和医疗机构直接接触药品的工作人员，必须每年进行健康检查。
Staff members of drug manufacturers, drug distributors and medical institutions who make a direct contact with drugs shall receive physical examination annually.

90.患有传染病或者其他可能污染药品的疾病的，不得从事直接接触药品的工作。
Those who suffer from infectious diseases or any other diseases that may cause drug contamination are not permitted to undertake any job in direct contact with drugs.

91. 直接接触药品的包装材料和容器，必须符合药用要求，符合保障人体健康、安全的标准，并由药品监督管理部门在审批药品时一并审批。
Immediate packaging materials and containers shall meet the requirements for medicinal use and comply with the standards for ensuring human health and safety. They along with the drugs shall be subject to reviewing and approval by the drug regulatory agency.

92. 药品包装必须按照规定印有或者贴有标签并附有说明书。
A label shall be printed or stuck on the drug package with an insert sheet attached as required by regulations.

93.标签或者说明书上必须注明药品的通用名称、成份、规格、生产企业、批准文号、产品批号、生产日期、有效期、适应症或者功能主治、用法、用量、禁忌、不良反应和注意事项。
In the label or insert sheet shall be indicated the adopted name of the drug, its ingredients, strength, manufacturer, approval number, product batch number, production date, date of expiry, indications or functions, usage, dosage, contraindications, drug adverse reactions, and precautions.

94.麻醉药品、精神药品、医疗用毒性药品、放射性药品、外用药品和非处方药的标签，必须印有规定的标志。
Specified marks shall be printed in the label of narcotic drugs, psychotropic substances, toxic drugs for medical use, radioactive pharmaceuticals, drugs for topical use, and non-prescription drugs.

95.药品的生产企业、经营企业和医疗机构必须执行政府定价、政府指导价，不得以任何形式擅自提高价格。
Drug manufacturers, drug distributors and medical institutions shall comply with the prices fixed or guided by the government. No one is permitted to raise prices in any manner without authorization.

96.禁止药品的生产企业、经营企业和医疗机构在药品购销中帐外暗中给予、收受回扣或者其他利益。
Drug manufacturers, drug distributors and medical institutions are prohibited from secret  offering or accepting rake-offs or other benefits (not shown in the account book) in the course of purchasing and selling drugs.

97.禁止药品的生产企业、经营企业或者其代理人以任何名义给予使用其药品的医疗机构的负责人、药品采购人员、医师等有关人员以财物或者其他利益。
Drug manufacturers, drug distributors or their agents are prohibited from offering, under any pretence, money or goods of value or other benefits to leading people, drug purchasers, physicians, or other related persons of the medical institutions where their drugs are purchased.

98.药品广告须经企业所在地省、自治区、直辖市人民政府药品监督管理部门批准，并发给药品广告批准文号；未取得药品广告批准文号的，不得发布。
Drug advertisement shall be subject to approval by the drug regulatory agencies of the government of the province, autonomous region or municipality directly under the Central Government where the enterprise is located and an approval number of drug advertisement shall he issued. No one is permitted to release advertisement without the approval number.

99.处方药可以在国务院卫生行政部门和国务院药品监督管理部门共同指定的医学、药学专业刊物上介绍，但不得在大众传播媒介发布广告或者以其他方式进行以公众为对象的广告宣传。
Prescription drugs may be introduced in the medical or pharmaceutical professional journals jointly designated by the administrative agency of health and the drug regulatory agency of the State Council,  but their advertisements are not permitted to be released by mass media or disseminated to the general public by other means.

100.药品广告的内容必须真实、合法，以国务院药品监督管理部门批准的说明书为准，不得含有虚假的内容。
The content of drug advertisement shall be truthful and lawful, and shall be based on the insert sheet approved by the drug regulatory agency of the State Council. The false content shall not be contained in advertisement.

101.药品广告不得含有不科学的表示功效的断言或者保证；不得利用国家机关、医药科研单位、学术机构或者专家、学者、医师、患者的名义和形象作证明。
No unscientific conclusion or guarantee on drug efficacy is permitted to be included in drug advertisement; names or images of government agencies, medical or pharmaceutical research institutions, academic institutions, or experts, scholars, physicians and patients are prohibited from being used as evidence for drug advertising.

102.非药品广告不得有涉及药品的宣传。
Non-drug advertisements not permitted to involve with drug promotion.

103.药品监督管理部门进行监督检查时，必须出示证明文件，对监督检查中知悉的被检查人的技术秘密和业务秘密应当保密。
When people from drug regulatory agencies conduct supervision and inspection, they shall show their identification documents, and shall keep confidential the technical and business secrets of the persons or the institutions under inspection that have been informed in the course of supervision and inspection.

104.药品监督管理部门根据监督检查的需要，可以对药品质量进行抽查检验。
Drug regulatory agencies may conduct selective testing of drug quality in light of the need of supervision and inspection.

105.抽查检验应当按照规定抽样，并不得收取任何费用。
Sampling for selective testing shall be carried out according to relevant regulations, and no fees are permitted to be charged for sampling or testing.

106.药品监督管理部门对有证据证明可能危害人体健康的药品及其有关材料可以采取查封、扣押的行政强制措施。
The drug regulatory agency shall take administrative enforcement to seal or seize the drugs and related materials proved to be potentially harmful to human health and shall.

107.药品监督管理部门应当按照规定，依据《药品生产质量管理规范》、《药品经营质量管理规范》，对经其认证合格的药品生产企业、药品经营企业进行认证后的跟踪检查。
Drug regulatory agencies shall, in accordance with regulations and on the basis of the GMP and GSP, make the follow-up inspection on the certified drug manufacturers and distributors.

108.地方人民政府和药品监督管理部门不得以要求实施药品检验、审批等手段限制或者排斥非本地区药品生产企业依照本法规定生产的药品进入本地区。
With regard to the drugs produced according to the provisions of this Law by drug manufacturers not located in the region, the local government and drug regulatory agency are not permitted to restrict or refuse their access to the region.

109.国家实行药品不良反应报告制度。
The State has established and exercised the reporting system on adverse drug reaction (ADR).

110.未取得《药品生产许可证》、《药品经营许可证》或者《医疗机构制剂许可证》生产药品、经营药品的，依法予以取缔
Without Drug Manufacturing Certificate, Drug Supply Certificate or Pharmaceutical Preparation Certificate for Medical Institution, the manufacturer or distributor of drug or medical institution shall be banned to produce or distribute drugs.

111.(1)生产、销售假药的，没收违法生产、销售的药品和违法所得，并处违法生产、销售药品货值金额二倍以上五倍以下的罚款；
Where counterfeit drugs are produced or sold, the drugs illegally produced or sold and the illegal income shall be confiscated, and a fine not less than two times but not more than five times the value of the said drugs shall be collected.

(2)有药品批准证明文件的予以撤销，并责令停产、停业整顿；
The approval documents, if any, shall be withdrawn and an order shall be given to suspend production or business operation for rectification.

(3)情节严重的，吊销《药品生产许可证》、《药品经营许可证》或者《医疗机构制剂许可证》；构成犯罪的，依法追究刑事责任。
If the circumstances are serious, the Drug Manufacturing Certificate, Drug Supply Certificate or Pharmaceutical Preparation Certificate for Medical Institution shall be revoked. If a crime is constituted, criminal liabilities shall be investigated under the law.

112.(1)生产、销售劣药的，没收违法生产、销售的药品和违法所得，并处违法生产、销售药品货值金额一倍以上三倍以下的罚款；
Where inferior drugs are produced or sold, the drugs illegally produced or sold and the illegal income shall be confiscated, and a fine not less than but not more than three times the value of the said drugs shall also be collected.
(2)情节严重的，责令停产、停业整顿或者撤销药品批准证明文件、吊销《药品生产许可证》、《药品经营许可证》或者《医疗机构制剂许可证》；
If the circumstances are serious, an order shall be given to suspend production or business operation for rectification, or the drug approval documents shall be withdrawn and the Drug Manufacturing Certificate, the Drug Supply Certificate, or the Pharmaceutical Preparation Certificate for Medical Institution shall be revoked.
(3)构成犯罪的，依法追究刑事责任。
If a crime is constituted, criminal liabilities shall be investigated under the law.

113.药品，是指用于预防、治疗、诊断人的疾病，有目的地调节人的生理机能并规定有适应症或者功能主治、用法和用量的物质，包括中药材、中药饮片、中成药、化学原料药及其制剂、抗生素、生化药品、放射性药品、血清、疫苗、血液制品和诊断药品等。
Drugs refer to the products that are used in the prevention, treatment and diagnosis of human diseases and intended for the regulation of the physiological functions of human beings, with specifications of indications, usage and dosage. They include Chinese crude drugs, prepared slices of Chinese crude drugs, traditional Chinese medicines, chemical drug substances (API) and their preparations, antibiotics, biochemical drugs, radioactive pharmaceuticals, serum, vaccines, blood products, and diagnostic agents.

114.辅料，是指生产药品和调配处方时所用的赋形剂和附加剂。
Excipients refer to the vehicles and additives intended for manufacturing drug dosage forms and prescription dispensing.

115.药品生产企业，是指生产药品的专营企业或者兼营企业。
Drug manufacturers refer to enterprises exclusively or partly engaged in drug production.

116.药品经营企业，是指经营药品的专营企业或者兼营企业。
Drug distributors refer to enterprises exclusively or partly engaged in drug distribution.

117.国务院药品监督管理部门负责全国的医疗器械监督管理工作。
The drug regulatory agency of the State Council is responsible for supervision and administration of medical devices nationwide.

118.国家对医疗器械实行分类管理。
The State shall carry out the policy of classification administration of medical devices.

119.国家对医疗器械实行产品生产注册制度。
The State shall implement a product registration system for manufacturing medical devices.

120.生产第一类医疗器械，由设区的市级人民政府药品监督管理部门审查批准，并发给产品生产注册证书。
Class I medical devices shall be inspected, approved and issued a registration certificate by the drug regulatory agency of the government of the municipalities with districts.

121.生产第二类医疗器械，由省、自治区、直辖市人民政府药品监督管理部门审查批准，并发给产品生产注册证书。
Class Ⅱ medical devices shall be inspected, approved and issued registration certificates by the drug regulatory agency of provinces, autonomous regions and municipalities directly of the Central Government.

122.生产第三类医疗器械，由国务院药品监督管理部门审查批准，并发给产品生产注册证书。生产第二类、第三类医疗器械，应当通过临床验证。
Class Ⅲ medical devices shall be inspected, approved and issued registration certificates by the drug regulatory agency directly under the State Council.

123.医疗器械产品注册证书有效期四年。
The term of validity for the registration certificate of medical devices is four years.

124.生产医疗器械，应当符合医疗器械国家标准；没有国家标准的，应当符合医疗器械行业标准。
Medical devices manufactured shall meet the national standard, or professional standards when there are no relevant national standards available.

125.医疗器械的使用说明书、标签、包装应当符合国家有关标准或者规定。
The instruction for use, label and package of medical devices shall comply with relevant standards or provisions in China.

126.医疗器械及其外包装上应当按照国务院药品监督管理部门的规定，标明产品注册证书编号。
The registration number of a medical device shall be marked on the product itself and on the external package according to the provisions of the drug regulatory agency of the State Council.

127.开办第一类医疗器械生产企业，应当向省、自治区、直辖市人民政府药品监督管理部门备案。
For the manufacturing of class I medical devices, it requires that the enterprise file a record with the drug regulatory agency of provinces, autonomous regio

作者: hy12134   发布日期: 2006-12-20